Literature DB >> 29767352

Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis.

Laura Fionda1, Fiammetta Vanoli2, Antonella Di Pasquale2, Luca Leonardi2, Stefania Morino2, Giovanni Antonini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29767352     DOI： 10.1007/s00415-018-8900-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Multifocal motor neuropathy with conduction block following treatment with infliximab.

Authors:  Claire E Barber; Peter Lee; A Hillary Steinhart; Jason Lazarou
Journal:  J Rheumatol       Date:  2010-08-01       Impact factor: 4.666

2.  Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features.

Authors:  E A Cats; B C Jacobs; N Yuki; A P Tio-Gillen; S Piepers; H Franssen; J-T van Asseldonk; L H van den Berg; W-L van der Pol
Journal:  Neurology       Date:  2010-10-20       Impact factor: 9.910

Review 3.  Neurological adverse events associated with anti-tumor necrosis factor α treatment.

Authors:  Antonio G Tristano
Journal:  J Neurol       Date:  2010-05-22       Impact factor: 4.849

Review 4.  Biologics for rheumatoid arthritis: an overview of Cochrane reviews.

Authors:  Jasvinder A Singh; Robin Christensen; George A Wells; Maria E Suarez-Almazor; Rachelle Buchbinder; Maria Angeles Lopez-Olivo; Elizabeth Tanjong Ghogomu; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

5.  Anti-TNF alpha medications and neuropathy.

Authors:  Pinelopi Tsouni; Olivier Bill; André Truffert; Christelle Liaudat; François Ochsner; Andreas J Steck; Thierry Kuntzer
Journal:  J Peripher Nerv Syst       Date:  2015-12       Impact factor: 3.494

6.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.